Acta Biologica Hungarica
Volume/Issue:
Volume 64: Issue 4
Cytotoxic and apoptotic functions of licofelone on rat glioma cells
Authors:
Gokhan Kus Anadolu University Department of Health Program, Open Faculty Eskisehir Turkey

Search for other papers by Gokhan Kus in
Current site
Google Scholar
PubMed Close
,
Pinar Oztopcu-Vatan Eskisehir Osmangazi University Department of Biology, Faculty of Arts and Sciences Eskisehir 26480 Turkiye

Search for other papers by Pinar Oztopcu-Vatan in
Current site
Google Scholar
PubMed Close
,
Ruhi Uyar Eskisehir Osmangazi University Department of Physiology, Faculty of Medicine Eskisehir 26480 Turkiye

Search for other papers by Ruhi Uyar in
Current site
Google Scholar
PubMed Close
, and
Selda Kabadere Eskisehir Osmangazi University Department of Physiology, Faculty of Medicine Eskisehir 26480 Turkiye

Search for other papers by Selda Kabadere in
Current site
Google Scholar
PubMed Close
Pages:
438–452
Online Publication Date:
25 Nov 2013
Publication Date:
01 Dec 2013
Article Category:
Research Article
DOI:
https://doi.org/10.1556/abiol.64.2013.4.4
Keywords:
Antiproliferative effects; apoptosis; arachidonic acid; glioma-licofelone
Restricted access

Gliomas are the largest group of central nervous system tumors and despite of clinical treatments death rate is very high. Inhibition of both cyclooxygenase and lipoxygenase pathways that take role in arachidonic acid metabolism prevents cancer development and induces apoptosis. One of the most promising compounds that blocks both of these pathways is licofelone. Using colchicine and 5-fluorouracil as positive controls, we questioned whether licofelone affects the survival of rat glioma cell line (C6) and induces apoptosis in vitro. After growing the cells in culture, we determined viability with MT, apoptosis with flow cytometry and activity of caspase enzymes with real time PCR. All used doses of colchicine and 5-fluorouracil were cytotoxic and reduced the number of surviving C6 cells as much as 44% and 60%, respectively. Comparing to the control, treatments with 10, 50 and 100 μM licofelone for 24 or 48 h did not influence C6 survival, however, 150, 200 and 250 μM licofelone reduced the number of living cells by 58, 88 and 93%, respectively, and induced apoptosis of C6 cells in a dose and time dependent manner. Licofelone did not change the level of caspase-9, but increased the level of caspase-3. Comparing with 5-fluorouracil and colchicine, the present study reveals for the first time the possibility that licofelone possesses a strong dose and time dependent antiproliferative and proapoptotic properties on glioma cells.

  • Boatright, K. M., Salvesen, G. S. (2003) Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15, 725–731.

    Salvesen G. S. , 'Mechanisms of caspase activation. Curr. Opin ' (2003 ) 15 Cell Biol. : 725 -731 .

    • Search Google Scholar

  • Cao, Y., Pearman, A. T., Zimmerman, G. A., McIntyre, T. M., Prescott, S. M. (2000) Intracellular unesterified arachidonic acid signals apoptosis. Proc. Natl Acad. Sci. (PNAS) 97, 11280–11285.

    Prescott S. M. , 'Intracellular unesterified arachidonic acid signals apoptosis ' (2000 ) 97 Proc. Natl Acad. Sci. (PNAS) : 11280 -11285 .

    • Search Google Scholar

  • Cicero, A. F., Derosa, G., Gaddi, A. (2005) Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone. Drugs Aging 225, 393–403.

    Gaddi A. , 'Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone ' (2005 ) 225 Drugs Aging : 393 -403 .

    • Search Google Scholar

  • Claria, J. (2003) Cyclooxygenase-2 biology. Curr. Pharm. Design 9, 2177–2190.

    Claria J. , 'Cyclooxygenase-2 biology ' (2003 ) 9 Curr. Pharm. Design : 2177 -2190 .

  • Ding, X. Z., Hennig, R., Adrian, T. E. (2003) Lipoxygenase and cyclooxygenase metabolism: New insights in treatment and chemoprevention of pancreatic cancer. Mol. Cancer. 2, 1–12.

    Adrian T. E. , 'Lipoxygenase and cyclooxygenase metabolism: New insights in treatment and chemoprevention of pancreatic cancer ' (2003 ) 2 Mol. Cancer : 1 -12 .

    • Search Google Scholar

  • Ding, X. Z., Iversen, P., Cluck, M. V., Knezetic, J. A., Adrian, T. E. (1999) Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem. Biophys. Res. Commun. 261, 218–223.

    Adrian T. E. , 'Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells ' (1999 ) 261 Biochem. Biophys. Res. Commun. : 218 -223 .

    • Search Google Scholar

  • Engeland, M. V., Nieland, J. W. L., Ramaekers, C. S., Schutte, B., Reutelingsperger, C. P. M. (1998) Annexin V-affinity assay: A review on a apoptosis detection system based on phosphatidylserine exposure. Cytometry 31, 1–9.

    Reutelingsperger C. P. M. , 'Annexin V-affinity assay: A review on a apoptosis detection system based on phosphatidylserine exposure ' (1998 ) 31 Cytometry : 1 -9 .

    • Search Google Scholar

  • Ganesh, R., Marks, D. J., Sles, K., Winslet, M. C., Seifalian, A. (2012) Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells. World J. Surg. Oncol. 26, 10, 1:200 (Epub ahead of print doi:10.1186/1477-7819-10-200)

    Seifalian A. , 'Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells ' (2012 ) 26 World J. Surg. Oncol. : 10 -.

    • Search Google Scholar

  • Gao, J., Fan, H. R., Mei, L. Y. (2010) Pharmacological activities and pharmacokinetics of licofelone. Asian J. Pharmacodynamics and Pharmacokinetics 4, 287–299.

    Mei L. Y. , 'Pharmacological activities and pharmacokinetics of licofelone ' (2010 ) 4 Asian J. Pharmacodynamics and Pharmacokinetics : 287 -299 .

    • Search Google Scholar

  • Ghosh, J., Myers, C. E. (1998) Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl Acad. Sci. (PNAS) 95, 13182–13187.

    Myers C. E. , 'Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells ' (1998 ) 95 Proc. Natl Acad. Sci. (PNAS) : 13182 -13187 .

    • Search Google Scholar

  • Gracia-Alvaro, J. M. (2004) Licofelone-clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis. Rheumatology 43, 21–25.

    Gracia-Alvaro J. M. , 'Licofelone-clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis ' (2004 ) 43 Rheumatology : 21 -25 .

    • Search Google Scholar

  • Grobben, B., De Deyn. P. P., Slegers, H. (2002) Rat C6 glioma as experimental system for the study of glioblastma growth and invasion. Cell Tissue Res. 310, 257–270.

    Slegers H. , 'Rat C6 glioma as experimental system for the study of glioblastma growth and invasion ' (2002 ) 310 Cell Tissue Res. : 257 -270 .

    • Search Google Scholar

  • Gumgumji, A. A., Dawood, T., Pervez, T. (2003) Role of COX-2 spesific inhibitors in oncogenesis. J. Coll. Physicians Surg. Pak. 3, 361–365.

    Pervez T. , 'Role of COX-2 spesific inhibitors in oncogenesis ' (2003 ) 3 J. Coll. Physicians Surg. Pak. : 361 -365 .

    • Search Google Scholar

  • Hajighasemi, F., Mirshafiey, A. (2009) In vitro sensitivity of leukemia cells to propranolol. J. Clin. Med. Res. 1, 144–149.

    Mirshafiey A. , 'In vitro sensitivity of leukemia cells to propranolol ' (2009 ) 1 J. Clin. Med. Res. : 144 -149 .

    • Search Google Scholar

  • Hoguei, A., Lippman, S. C., Wu, T. T., Xu, Y., Liang, Z. D., Swisher, S., Zhang, H., Cao, L., Ajani, J. A., Xu, X. (2005) Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis 26, 785–791.

    Xu X. , 'Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention ' (2005 ) 26 Carcinogenesis : 785 -791 .

    • Search Google Scholar

  • Huerta, S., Gaulet, E. J., Haerta-Yepez, S., Livingston, E. H. (2007) Screening and detection of apoptosis. J. Surg. Res. 1, 143–156.

    Livingston E. H. , 'Screening and detection of apoptosis ' (2007 ) 1 J. Surg. Res. : 143 -156 .

    • Search Google Scholar

  • Hyde, C. A. C., Missailidis, S. (2009) Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. International Immunopharmacol. 9, 701–715.

    Missailidis S. , 'Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis ' (2009 ) 9 International Immunopharmacol : 701 -715 .

    • Search Google Scholar

  • Jemal, A., Siegel, R., Word, E., Hao, Y., Xu, J., Thun, M. J. (2009) Cancer statistics. CA-Cancer J. Clin. 59, 225–249.

    Thun M. J. , 'Cancer statistics ' (2009 ) 59 CA-Cancer J. Clin. : 225 -249 .

  • Kamijo, T., Sato, T., Nagotomi, Y., Kitamura, T. (2001) Induction apoptosis by cyclooxygenase-2 inhibitors in prostate cell lines. Int. J. Urol. 8, 35–39.

    Kitamura T. , 'Induction apoptosis by cyclooxygenase-2 inhibitors in prostate cell lines ' (2001 ) 8 Int. J. Urol. : 35 -39 .

    • Search Google Scholar

  • Kemerli, C., Taskin, M., Sutpideler, N., Kaplan, N., Ethemoglu, B. (2005) Histopathology, invasion, migration and tumorigenicity in the C6 rat glioma model. Turkish Neurosurg. 15, 109–115.

    Ethemoglu B. , 'Histopathology, invasion, migration and tumorigenicity in the C6 rat glioma model ' (2005 ) 15 Turkish Neurosurg : 109 -115 .

    • Search Google Scholar

  • Kurkjian, C., Janakiram, N. B., Guruswamy, S., Rao, C. V., Ozer, H. (2007) The effects of licofelone, a dual lipoxygenase and cyclooxygenase inhibitor, with and without rosiglitazone in human MCF-7 and MDA-MB-231 breast cancer cells. J. Clin. Oncol. 25, 1537.

    Ozer H. , 'The effects of licofelone, a dual lipoxygenase and cyclooxygenase inhibitor, with and without rosiglitazone in human MCF-7 and MDA-MB-231 breast cancer cells ' (2007 ) 25 J. Clin. Oncol. : 1537 -.

    • Search Google Scholar

  • Lu, Y. Y., Chen, T. S., Qu, J. L., Pan, W. L., Sun, L., Wei, X. B. (2009) Dihydroartemisinin induces caspase-3 dependent apoptosis in human lung adenocarcinoma ASTC cells. J. Biomed. Sci. 16, 16–32.

    Wei X. B. , 'Dihydroartemisinin induces caspase-3 dependent apoptosis in human lung adenocarcinoma ASTC cells ' (2009 ) 16 J. Biomed. Sci. : 16 -32 .

    • Search Google Scholar

  • Mohammed, A., Janakiram, N. B., Li, Q., Choi, C., Zhang, Y., Steele, V. E., Rao, C. V. (2011) Chemoprevention of colon and small intestinal tumorigenesis in apcmin/+ mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention. Cancer Prev. Res. 4, 2015–2026.

    Rao C. V. , 'Chemoprevention of colon and small intestinal tumorigenesis in apcmin/+ mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention ' (2011 ) 4 Cancer Prev. Res. : 2015 -2026 .

    • Search Google Scholar

  • Mossmann, T. (1983) Rapid colorimetric assay of cellular growth and survival: Application to proliferation and cytotoxicity assay. J. Immun. Method 65, 55–63.

    Mossmann T. , 'Rapid colorimetric assay of cellular growth and survival: Application to proliferation and cytotoxicity assay ' (1983 ) 65 J. Immun. Method : 55 -63 .

    • Search Google Scholar

  • Mueller, T., Voigt. W., Simon, H., Fruehauf, A., Bulankin, A., Grothey, A., Schmull, H. J. (2003) Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res. 63, 513–521.

    Schmull H. J. , 'Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer ' (2003 ) 63 Cancer Res. : 513 -521 .

    • Search Google Scholar

  • Narayanan, K., Nargi, D., Attur, M., Abramson, S. B., Narayanan, B. A. (2007) Anticancer effects of licofelone in prostate cancer cells. Anticancer Res. 27, 2393–2402.

    Narayanan B. A. , 'Anticancer effects of licofelone in prostate cancer cells ' (2007 ) 27 Anticancer Res. : 2393 -2402 .

    • Search Google Scholar

  • New, P. (2004) Cyclooxygenase in the treatment of glioma: Its complex role in signal transduction. Cancer Control 11, 52–64.

    New P. , 'Cyclooxygenase in the treatment of glioma: Its complex role in signal transduction ' (2004 ) 11 Cancer Control : 52 -64 .

    • Search Google Scholar

  • O’Donovan, N., Crown, J., Stunell, H., Hill, A. D. K., Mcdermott, E., O’Higgins, N., Duffy, M. J. (2003) Caspase 3 in breast cancer. Clin. Can. Res. 9, 738–742.

    Duffy M. J. , 'Caspase 3 in breast cancer ' (2003 ) 9 Clin. Can. Res. : 738 -742 .

  • Ravindran, J., Prasad, S., Aggarwal, B. B. (2009) Circumin and cancer cells: How many ways can curry kill tumor cells selectively? AAPS J. 11, 495–510.

    Aggarwal B. B. , 'Circumin and cancer cells: How many ways can curry kill tumor cells selectively ' (2009 ) 11 AAPS J. : 495 -510 .

    • Search Google Scholar

  • Romano, M., Claria, J. (2003) Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J. 17, 1986–1995.

    Claria J. , 'Cyclooxygenase-2 and 5-Lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy ' (2003 ) 17 FASEB J. : 1986 -1995 .

    • Search Google Scholar

  • Salseven, G. S., Dixit, V. M. (1999) Caspase activation: The induced proximity model. Proc. Natl Acad. Sci. (PNAS) 96, 10964–10967.

    Dixit V. M. , 'Caspase activation: The induced proximity model ' (1999 ) 96 Proc. Natl Acad. Sci. (PNAS) : 10964 -10967 .

    • Search Google Scholar

  • Sanchez, C., Ceballos, M. L., Pulgar, T. G., Rueda, D., Corbacho, D., Velasco, G., Roperh, G., Huffman, J. W., Cajal, S. R., Guzma, M. (2001) Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor. Cancer Res. 61, 5784–5789.

    Guzma M. , 'Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor ' (2001 ) 61 Cancer Res. : 5784 -5789 .

    • Search Google Scholar

  • Sánchez-Alcázar, J. A., Bradbury, D. A., Pang, L., Knox, A. J. (2003) Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways. Lung Cancer 40, 33–44.

    Knox A. J. , 'Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways ' (2003 ) 40 Lung Cancer : 33 -44 .

    • Search Google Scholar

  • Schroeder, C. P., Yang, P., Newman, R. A., Lotan, R. (2007) Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines. Exp. Ther. Oncol. 6, 183–192.

    Lotan R. , 'Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines ' (2007 ) 6 Exp. Ther. Oncol. : 183 -192 .

    • Search Google Scholar

  • Sigal, E. (1991) The molecular biology of mammalian arachidonic acid metabolism. Am. J. Phsiol. 260, 13–28.

    Sigal E. , 'The molecular biology of mammalian arachidonic acid metabolism ' (1991 ) 260 Am. J. Phsiol. : 13 -28 .

    • Search Google Scholar

  • Tavolari, S., Bonafè, M., Marini, M., Ferreri, C., Bartolini, G., Brighenti, E., Manara, S., Tomasi, V., Laufer. S., Guarnieri, T. (2008) Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade. Carcinogenesis 29, 371–380.

    Guarnieri T. , 'Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade ' (2008 ) 29 Carcinogenesis : 371 -380 .

    • Search Google Scholar

  • Tong, W. G., Ding, X. Z., Witt, R. C., Adrian, T. E. (2002) Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol. Cancer Ther. 1, 929–935.

    Adrian T. E. , 'Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway ' (2002 ) 1 Mol. Cancer Ther. : 929 -935 .

    • Search Google Scholar

  • Wenning, L., Sung, P., Yang, L., Wang, J., Li, L., Wang, J. (2010) Assay of glioma cell responses to an anticancer drug in a cell-based microfluid device. Microfluid Nanofluid. 9, 717–725.

    Wang J. , 'Assay of glioma cell responses to an anticancer drug in a cell-based microfluid device ' (2010 ) 9 Microfluid Nanofluid : 717 -725 .

    • Search Google Scholar

  • Ye, N. Y., Wu, W. K. K., Shin, V. Y., Bruce, I. C., Wong, B. C. Y., Cho, C. H. (2005) Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. Carcinogenesis 26, 827–834.

    Cho C. H. , 'Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke ' (2005 ) 26 Carcinogenesis : 827 -834 .

    • Search Google Scholar

  • Zeldin, D. C. (2001) Epoxygenase of arachidonic acid metabolism. J. Biol. Chem. 276, 36059–36062.

    Zeldin D. C. , 'Epoxygenase of arachidonic acid metabolism ' (2001 ) 276 J. Biol. Chem. : 36059 -36062 .

    • Search Google Scholar

  • Zhang, B., Wang, C. L., Zhao, W. H., Lv, M., Wang, C. Y., Zhong, W. X., Zhou, W. Y., Yu, W. S., Zhang, Y., Li, S. (2008) Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2. World J. Gastroenterol. 28, 2494–2500.

    Li S. , 'Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2 ' (2008 ) 28 World J. Gastroenterol : 2494 -2500 .

    • Search Google Scholar
  • Collapse
  • Expand
Cover Acta Biologica Hungarica
Acta Biologica Hungarica
Print ISSN:
0236-5383
Online ISSN:
1588-256X

Senior editors

Editor(s)-in-Chief: Elekes, Károly

Editorial Board

    1. Csányi, Vilmos (Göd)
    1. Dudits, Dénes (Szeged)
    1. Falus, András (Budapest)
    1. Fischer, Ernő (Pécs)
    1. Gábriel, Róbert (Pécs)
    1. Gulya, Károly (Szeged)
    1. Gulyás, Balázs (Stockholm)
    1. Hajós, Ferenc (Budapest)
    1. Hámori, József (Budapest)
    1. Heszky, László (Gödöllő)
    1. Hideg, Éva (Szeged)
    1. E. Ito (Sanuki)
    1. Janda, Tibor (Martonvásár)
    1. Kavanaugh, Michael P. (Missoula)
    1. Kása, Péter (Szeged)
    1. Klein, Éva (Stockholm)
    1. Kovács, János (Budapest)
    1. Brigitte Mauch-Mani (Neuchâtel)
    1. Nässel, Dick R. (Stockholm)
    1. Nemcsók, János (Szeged)
    1. Péczely, Péter (Gödöllő)
    1. Roberts, D. F. (Newcastle-upon-Tyne)
    1. Sakharov, Dimitri A. (Moscow)
    1. Singh, Meharvan (Fort Worth)
    1. Sipiczky, Mátyás (Debrecen)
    1. Szeberényi, József (Pécs)
    1. Székely, György (Debrecen)
    1. Tari, Irma (Szeged)
    1. Vágvölgyi, Csaba (Szeged),
    1. L. Zaborszky (Newark)

 

Acta Biologica Hungarica
P.O. Box 35
H-8237 Tihany, Hungary
Phone: (36 87) 448 244 ext. 103
Fax: (36 87) 448 006
E-mail: elekes@tres.blki.hu

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Current Contents: Agriculture
  • Biology and Environmental Sciences
  • Elsevier BIOBASE
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • Science Citation Index
  • Science Citation Index Expanded (SciSearch)
  • SCOPUS
  • The ISI Alerting Services
  • Zoological Abstracts

 

Acta Biologica Hungarica
Language English
Size  
Year of
Foundation		 1950
Publication
Programme		 changed title
Volumes
per Year		  
Issues
per Year		  
Founder Magyar Tudományos Akadémia
Founder's
Address		 H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-5383 (Print)
ISSN 1588-256X (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Dec 2024 25 0 0
Jan 2025 37 0 0
Feb 2025 44 0 0
Mar 2025 50 0 0
Apr 2025 18 0 0
May 2025 3 0 0
Jun 2025 0 0 0